Endo Operations Company Profile

✉ Email this page to a colleague

ENDO OPERATIONS has two hundred and twenty-one approved drugs.

There are forty-one US patents protecting ENDO OPERATIONS drugs. There is one tentative approval on ENDO OPERATIONS drugs.

There are one hundred and nineteen patent family members on ENDO OPERATIONS drugs in forty countries and three hundred and fifty-three supplementary protection certificates in seventeen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Operations	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-002	Apr 21, 2023		RX	Yes	Yes	11,083,698	⤷ Sign Up				⤷ Sign Up
Endo Operations	DOXYCYCLINE HYCLATE	doxycycline hyclate	INJECTABLE;INJECTION	216690-001	Dec 7, 2022		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Endo Operations	VASOSTRICT	vasopressin	SOLUTION;INTRAVENOUS	204485-003	Apr 15, 2020		RX	Yes	Yes	9,919,026	⤷ Sign Up	Y			⤷ Sign Up
Endo Operations	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	040218-001	Sep 11, 1997		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Operations	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021610-004	Jun 22, 2006	7,276,250	⤷ Sign Up
Endo Operations	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021610-006	Feb 29, 2008	7,276,250	⤷ Sign Up
Endo Operations	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021610-003	Jun 22, 2006	7,276,250	⤷ Sign Up
Endo Operations	OPANA ER	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021610-002	Jun 22, 2006	5,128,143	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	1%	➤ Subscribe	2008-08-21
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Injection	1 mg/mL ampules	➤ Subscribe	2016-03-09
➤ Subscribe	Extended-release Tablets	5 mg, 10 mg, 20 mg and 40 mg	➤ Subscribe	2007-11-23
➤ Subscribe	Extended-release Tablets	30 mg	➤ Subscribe	2008-06-12
➤ Subscribe	Gel	10 mg/actuation	➤ Subscribe	2012-08-14
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	250 mg/mL	➤ Subscribe	2014-06-11
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	Injection	20 units/mL, 1 mL	➤ Subscribe	2018-03-23
➤ Subscribe	Extended-release Tablets	7.5 mg and 15 mg	➤ Subscribe	2008-05-29
➤ Subscribe	Tablets	2.5 mg	➤ Subscribe	2011-03-09
➤ Subscribe	Nasal Spray	500 mcg/spray	➤ Subscribe	2017-04-28

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Poland	1457208	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2006009801	⤷ Sign Up
Japan	4865990	⤷ Sign Up
Australia	2006262144	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1534313	15C0090	France	⤷ Sign Up	PRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728
1044189	SPC/GB08/034	United Kingdom	⤷ Sign Up	PRODUCT NAME: VARENICLINE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING THE TARTRATE SALT; REGISTRATION NO/DATE: EU/1/06/360/001 - 010 20060928
0663916	14/2004	Austria	⤷ Sign Up	PRODUCT NAME: EVEROLIMUS (40-0-(2-HYDROXY)ETYHL RAPAMYCIN); NAT. REGISTRATION NO/DATE: 1-25271;1-25272; 1-25275,1-25276. 20040302; FIRST REGISTRATION: SE 18690;18691;18692; 18693;18694;18695. 20030718
0265685	C980030	Netherlands	⤷ Sign Up	PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.